ABBVIE INC.

ABBV
Real-time Estimate Quote. Real-time Estimate  - 08/10 10:05:00 am
93.155USD +0.25%
Prev.92.9200
Open92.6300
High93.2000
Low92.1500
Volume5 227 010
Latest news
3d ago
5d ago
6d ago
6d ago
Chart ABBVIE INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBullishBullish
Resistance96,8101101
Spread/Res.-3,8%-7,6%-7,6%
Spread/Supp.0,62%16%15%
Support92,680,481,0
Financials
Sales 2020 45 512 M - -
Net income 2020 11 877 M - -
Net Debt 2020 74 289 M - -
P/E ratio 2020 15,6x
Yield 2020 5,25%
Capitalization 164 B 164 B -
EV / Sales 2020 5,24x
EV / Sales 2021 4,19x
Nbr of Employees 47 000
Free-Float 98,5%
Company
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn‚'Ts disease, thyroid disease, Parkinson‚'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with...
Sector :
Pharmaceuticals - NEC
Calendar :
2020-10-30 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 18
Average target price 106,78 $
Last Close Price 92,92 $
Spread / Highest target 36,7%
Spread / Average Target 14,9%
Spread / Lowest Target -24,7%